Clinical Trial Update: Study to Assess the Effect of the Aerobika Device in Addition to Standard of Care Treatment in Sputum Producing COPD Patients Using FRI [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the Aerobika device plus standard care in sputum-producing COPD patients was completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Aerobika device

Snippet

Sponsor: FLUIDDA nv | Conditions: Pulmonary Disease, Chronic Obstructive, COPD | Phase 4 | Status: COMPLETED